Denali Therapeutics (NASDAQ:DNLI) Hits New 52-Week Low at $14.56

Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $14.56 and last traded at $14.79, with a volume of 172121 shares changing hands. The stock had previously closed at $15.56. Analyst Ratings Changes DNLI has been the […]

Related Keywords

Los Angeles ,California ,United States ,Stevee Krognes ,Bryanj Watts , ,Los Angeles Capital Management ,Financial Services Group Inc ,Nasdaq ,Goldman Sachs Group ,Fisher Asset Management ,Vanguard Group Inc ,Denali Therapeutics Inc ,Securities Exchange Commission ,Denali Therapeutics ,Get Free Report ,Exchange Commission ,Director Steve ,Angeles Capital Management ,Services Group ,Therapeutics Inc ,Denali Therapeutics Daily ,Nasdaq Dnli ,Dnli ,Medical ,Stocks ,Technicals ,